Rezultaty - Heitz, Florian
- Rezultaty 1 - 20 Rezultaty od 63
- Idź do następnej strony
-
1
Response to the letter of Fagotti et al. regarding the manuscript: “Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfr... od Heitz, Florian, Harter, Philipp, Ataseven, Beyhan, du Bois, Andreas
Wydane 2016Text -
2
-
3
Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience od Moubarak, Malak, Harter, Philipp, Ataseven, Beyhan, Traut, Alexander, Welz, Julia, Baert, Thais, Heitz, Florian
Wydane 2022Text -
4
Incidence Patterns and Temporal Trends of Invasive Nonmelanotic Vulvar Tumors in Germany 1999-2011. A Population-Based Cancer Registry Analysis od Buttmann-Schweiger, Nina, Klug, Stefanie J., Luyten, Alexander, Holleczek, Bernd, Heitz, Florian, du Bois, Andreas, Kraywinkel, Klaus
Wydane 2015Text -
5
-
6
Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study od Maritschnegg, Elisabeth, Heitz, Florian, Pecha, Nina, Bouda, Jirí, Trillsch, Fabian, Grimm, Christoph, Vanderstichele, Adriaan, Agreiter, Christiane, Harter, Philipp, Obermayr, Eva, Vergote, Ignace, Zeillinger, Robert, Speiser, Paul
Wydane 2018Text -
7
Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy od Heitz, Florian, Kümmel, Sherko, Lederer, Bianca, Solbach, Christine, Engels, Knut, Ataseven, Beyhan, Sinn, Bruno, Blohmer, Jens Uwe, Denkert, Carsten, Barinoff, Jana, Fisseler-Eckhoff, Annette, Loibl, Sibylle
Wydane 2019Text -
8
Prevalence of BRCA1 and BRCA2 Mutations in Patients with Primary Ovarian Cancer – Does the German Checklist for Detecting the Risk of Hereditary Breast and Ovarian Cancer Adequatel... od Ataseven, Beyhan, Tripon, Denise, Rhiem, Kerstin, Harter, Philipp, Schneider, Stephanie, Heitz, Florian, Baert, Thais, Traut, Alexander, Pauly, Nina, Ehmann, Sarah, Plett, Helmut, Schmutzler, Rita K., du Bois, Andreas
Wydane 2020Text -
9
Dataset on patients with Recurrent Borderline Ovarian Tumors and Table with Review of Literature on Fertility and Oncologic Outcomes of patients with Borderline Ovarian Tumors od Plett, Helmut, Ricciardi, Enzo, Harter, Philipp, Ataseven, Beyhan, Heitz, Florian, Prader, Sonia, Schneider, Stephanie, Heikaus, Sebastian, Fisseler-Eckhoff, Annette, Kommoss, Friedrich, Lax, Sigurd F., Staebler, Annette, Traut, Alexander, du Bois, Andreas
Wydane 2020Text -
10
Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging od Kulbe, Hagen, Klein, Oliver, Wu, Zhiyang, Taube, Eliane T., Kassuhn, Wanja, Horst, David, Darb-Esfahani, Silvia, Jank, Paul, Abobaker, Salem, Ringel, Frauke, du Bois, Andreas, Heitz, Florian, Sehouli, Jalid, Braicu, Elena I.
Wydane 2020Text -
11
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet od Kolberg-Liedtke, Cornelia, Wuerstlein, Rachel, Gluz, Oleg, Heitz, Florian, Freudenberger, Muriel, Bensmann, Elena, du Bois, Andreas, Nitz, Ulrike, Pelz, Enrico, Warm, Matthias, Ortmann, Monika, Sultova, Elena, Brucker, Sara Y., Kates, Ronald E., Fehm, Tanja, Harbeck, Nadia
Wydane 2021Text -
12
Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC) od Fotopoulou, Christina, Rockall, Andrea, Lu, Haonan, Lee, Philippa, Avesani, Giacomo, Russo, Luca, Petta, Federica, Ataseven, Beyhan, Waltering, Kai-Uwe, Koch, Jens Albrecht, Crum, William R., Cunnea, Paula, Heitz, Florian, Harter, Philipp, Aboagye, Eric O., du Bois, Andreas, Prader, Sonia
Wydane 2021Text -
13
The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors: an analysis of the CORSETT da... od Hasenburg, Annette, Plett, Hellmut, Krämer, Bernhard, Braicu, Elena, Czogalla, Bastian, Bossart, Michaela, Singer, Susanne, Mayr, Doris, Staebler, Annette, du Bois, Andreas, Kommoss, Stefan, Link, Theresa, Burges, Alexander, Heitz, Florian, Keul, Jacqueline, Trillsch, Fabian, Harter, Philipp, Wimberger, Pauline, Buderath, Paul, Klar, Maximilian
Wydane 2021Text -
14
Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer—Impact for Diagnosis and Treatment Monitoring od Braicu, Elena Ioana, du Bois, Andreas, Sehouli, Jalid, Beck, Julia, Prader, Sonia, Kulbe, Hagen, Eiben, Bernd, Harter, Philipp, Traut, Alexander, Pietzner, Klaus, Glaubitz, Ralf, Ataseven, Beyhan, Chekerov, Radoslav, Keck, Christoph, Winkler, Thomas, Heikaus, Sebastian, Gellendin, Peggy, Schütz, Ekkehard, Heitz, Florian
Wydane 2021Text -
15
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study od Roncolato, Felicia T., Joly, Florence, O'Connell, Rachel, Lanceley, Anne, Hilpert, Felix, Buizen, Luke, Okamoto, Aikou, Aotani, Eriko, Pignata, Sandro, Donnellan, Paul, Oza, Amit, Avall‐Lundqvist, Elisabeth, Berek, Jonathan S., Heitz, Florian, Feeney, Amanda, Berton‐Rigaud, Dominique, Stockler, Martin R., King, Madeleine, Friedlander, Michael
Wydane 2017Text -
16
Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions od Winterhoff, Boris, Kommoss, Stefan, Heitz, Florian, Konecny, Gottfried E, Dowdy, Sean C, Mullany, Sally A, Park-Simon, Tjoung-Won, Baumann, Klaus, Hilpert, Felix, Brucker, Sara, du Bois, Andreas, Schröder, Willibald, Burges, Alexander, Shen, Steven, Wang, Jinhua, Tourani, Roshan, Ma, Sisi, Pfisterer, Jacobus, Aliferis, Constantin F.
Wydane 2018Text -
17
Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer od Heitz, Florian, Lakis, Sotirios, Harter, Philipp, Heikaus, Sebastian, Sehouli, Jalid, Talwar, Jatin, Menon, Roopika, Ataseven, Beyhan, Bertrand, Miriam, Schneider, Stephanie, Mariotti, Erika, Bommert, Mareike, Müller, Judith N., Prader, Sonia, Leenders, Frauke, Hengsbach, Alexandra, Gloeckner, Christian, Braicu, Elena Ioana, Heukamp, Lukas C., du Bois, Andreas, Heuckmann, Johannes M.
Wydane 2022Text -
18
Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy od Chenevix-Trench, Georgia, Lu, Yi, Johnatty, Sharon, Gamazon, Eric, Beesley, Jonathan, Chen, Xiaoqing, Gao, Bo, Harnett, Paul, Stephanie Huang, R, Despierre, Evelyn, Heitz, Florian, Hogdall, Estrid, Hogdall, Claus, Brown, Robert, Moyisch, Kirsten, Fasching, Peter, Goode, Ellen, Russell, Amanda, Henderson, Michelle, Haber, Michelle, Dolan, Eileen, Macgregor, Stuart, deFazio, Anna
Wydane 2012Text -
19
Clonal Hematopoiesis–Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer od Weber-Lassalle, Konstantin, Ernst, Corinna, Reuss, Alexander, Möllenhoff, Kathrin, Baumann, Klaus, Jackisch, Christian, Hauke, Jan, Dietrich, Dimo, Borde, Julika, Park-Simon, Tjoung-Won, Hanker, Lars, Prieske, Katharina, Schmidt, Sandra, Weber-Lassalle, Nana, Pohl-Rescigno, Esther, Kommoss, Stefan, Marmé, Frederik, Heitz, Florian, Stingl, Julia C, Schmutzler, Rita K, Harter, Philipp, Hahnen, Eric
Wydane 2021Text -
20
Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium od Babic, Ana, Cramer, Daniel W., Kelemen, Linda E., Köbel, Martin, Steed, Helen, Webb, Penelope M., Johnatty, Sharon E., deFazio, Anna, Lambrechts, Diether, Goodman, Marc T., Heitz, Florian, Matsuo, Keitaro, Hosono, Satoyo, Karlan, Beth Y., Jensen, Allan, Kjær, Susanne K., Goode, Ellen L., Pejovic, Tanja, Moffitt, Melissa, Høgdall, Estrid, Høgdall, Claus, McNeish, Iain, Terry, Kathryn L.
Wydane 2017Text